Arkolith/Insider Trading/EYPT/Form 4

Ribeiro Ramiro

Chief Medical OfficerEyePoint, Inc. (EYPT) · full profile →Form 4 · filed Feb 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$37K
Net Open-Market Flow
-$37K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 17, 2026Sell(S)2K$15.00$37K0
Feb 17, 2026Option exercise(M)2K$8.26$20K2K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 17, 2026Option exercise(M)2K—$085K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002013623-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML